1,5-Benzodiazepin-2(3H)-ones: In Vitro Evaluation as Antiparkinsonian Agents
A new series of twenty-three 1,5-benzodiazepin-2(3H)-ones were synthesized and evaluated in the 2,2'-azino-bis(3-ethylbenzothiazoline-6-sulfonic acid (ABTS), ferric reducing antioxidant power (FRAP), and 2,2-diphenyl-1-picrylhydrazyl (DPPH) assays as a new chemotype with antioxidant and good dr...
Saved in:
Main Authors: | Ana Ortíz de Zárate (Author), Marta Pérez-Torralba (Author), Iñigo Bonet Isidro (Author), Concepción López (Author), Rosa M. Claramunt (Author), Diana Martínez-Casanova (Author), Isabel Sánchez-Vera (Author), Jesús Jiménez-González (Author), José Luis Lavandera (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2021-10-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Antiparkinsonian Agents in Investigational Polymeric Micro- and Nano-Systems
by: Nicola Paccione, et al.
Published: (2022) -
Importance of Nanoparticles for the Delivery of Antiparkinsonian Drugs
by: Sara Silva, et al.
Published: (2021) -
Synthesis and Pharmacological Valorization of Derivatives of 4-Phenyl-1,5-Benzodiazepin-2-One
by: Terence Nguema Ongone, et al.
Published: (2018) -
PHARMACOKINETIC STUDIES OF NEW ANTIPARKINSONIAN DRUG RAPITALAM
by: Natalya Avdeeva, et al.
Published: (2016) -
Antiparkinsonian Efficacy of Guanosine in Rodent Models of Movement Disorder
by: Caio M. Massari, et al.
Published: (2017)